The in vivo effect of Echinacea purpurea succus on various functions of human blood leukocytes

Central-European Journal of Immunology

Volumn 28, Issue 3, 2003, Pages 126-130

  Skopińska Rózewska, Ewa ^a   Sokolnicka, Irena ^a   Radomska Leśniewska, Dorota ^a   Kapałka, Beata ^a   Sommer, Ewa ^a   Białas Chromiec, Beata ^a   Filewska, Małgorzata ^a   Demkow, Urszula ^a  

^a NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

Author keywords

Blood leukocytes; Echinacea purpurea; Human volunteers; In vivo treatment

Indexed keywords

CD19 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; ECHINACEA EXTRACT; GROWTH FACTOR; IMMUNAL; LYMPHOCYTE SURFACE MARKER; MITOGENIC AGENT; PHYTOHEMAGGLUTININ; PLACEBO; THYMIDINE;

ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CELL ASSAY; CELLULAR IMMUNITY; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG EFFECT; ECHINACEA PURPUREA; EVALUATION; FEMALE; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VIVO STUDY; LEUKOCYTE CULTURE; LEUKOCYTE FUNCTION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PARAMETER; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN SECRETION;

EID: 20444441996     PISSN: 14263912     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Awang DVC (1999): Immune stimulants and antiviral botanicals: Echinacea and Ginseng. In: Perspectives on new crops and new uses. Ed J. Janick ASHS Press, Alexandria, VA, 450-456. also: www.hort.purdue.edu/newcrop/ proceedings1999/v4-450.html
2. McLaughlin G (1992): Echinacea. Aust J Med Herbalism 4: 104-111.
3. Bauer R and Wagner H (1988): Echinacea Der Sonnehut Stand der Forschung. Zeitschrift fur Phytotherapie 9: 151-159, 1991.
4. Echinacea Species as Potential Immunostimulatory Drugs. Pp. 253-322 in Wagner H and Farnsworth NR (eds). Economic and Medicinal Plant Research. Vol 5. Orlando, Fla: Academic Press.
5. Facino RM, Carini M, Aldini G, et al. (1995): Echinacoside and caffeoyl conjugates protect collagen from free radical - induced degradation: A potential use of Echinacea extracts in the prevention of skin photodamage. Planta Med 61: 510-514.
6. Clifford LJ, Nair MG, Rana J, Dewitt DL (2002): Bioactivity of alkamides isolated from Echinacea purpurea (L) Moench. Phytomedicine 9: 249-253.
7. Goel V, Chang CH, Slama JV, et al. (2002): Alkylamides of Echinacea purpurea stimulate alveolar macrophage function in normal rats. International Immunopharmacology 2: 381-387. www.elsevier.com/locate/intimp
8. See DM, Broumand N, Sahl L, Tilles JG (1997): In vitro effects of Echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients. Immunopharmacology 35: 229-235.
9. Melchart D, Clemm C, Weber B, et al. (2002): Polysaccharides isolated from Echinacea purpurea herba cell cultures to counteract undesired effects of chemotherapy-a pilot study. Phytother Res 16: 138-142.
10. Roesler J, Steinmüller C, Kiderlen A, et al. (1991): Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to mice mediates protection against systemic infections with Listeria monocytogenes and Candida albicans. Int J Immunopharmar 13: 27-37.
11. Schimmel KCH and Werner GT (1981): Nonspecific enhancement of intrinsic resistance to infection by Echinacin®. Ther d Gegenw 120: 1065-1076.
12. Burger RA, Torres AR, Warren RP, et al. (1997): Echinacea-induced cytokine production by human macrophages. Int J Immunopharmacol Jul 19, 7: 371-379.
13. Luettig B, Steinmuller C, Gifford GE, et al. (1998): Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea. J Natl Cancer 81 (9): 669-675.
14. Skopińska-Różewska E, Wojtasik E. Immunotropowe dzialanie jeżówek (Echinacea purpurea, Echinacea pallida, Echinacea angustifolia). In: Wpływ substancji naturalnych na układ odpornościowy, Ed E Skopińska-Różewska: Fundacja Pomocy Zdrowiu - Medycyna Naturalna, Warszawa 2002; 32-42.
15. Barrett BP, Brown RL, Locken K, et al. (2002): Treatment of the common cold with unrefined Echinacea. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 137: 939-946.
16. Schwarz E, Metzler J, Diedrich JP, et al. (2002): Oral administration of freshly expressed juice of Echinacea purpurea herbs fail to stimulate the nonspecific immune response in healthy young men: results of double-blind, placebo-controlled crossover study. J Immunol 25: 413-420.
17. Melchart D, Walther E, Linke K, et al. (1998): Echinacea root extracts for the prevention of upper respiratory tract infections. Arch Farm Med 7: 541-545.
18. Grimm W, Müller HH (1999): A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections. Am J Med 106: 138-143.
19. Brinkeborn RM, Shah DV, Degenring PH (1999): Echinaforce and other Echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo controlled, double-blind clinical trial. Phytomedicine 6: 1-6.
20. Hoheisel O, Sandberg M, Bertram S, et al. (1997): Echinagard treatment shortens the course of the common cold: a double-blind, placebo-controlled clinical trial. Eur J Clin Res 9: 261-268.
21. Scaglione F, Lund B (1995): Efficacy in the treatment of the common cold of a preparation containing an Echinacea extract. Int J Immunotherapy 11: 163-166.
22. Kim LS, Waters RF, Burkholder PM (2002): Immunological activity of larch arabinogalactan and Echinacea: a preliminary, randomized, double-blind, placebo-controlled trial. Altern Med Rev 7: 138-149.
23. Binns SE, Hudson J, Merali S, Arnason JT (2002): Antiviral activity of characterized extracts from Echinacea sp (Heliantheae: Asteraceae) against herpes simplex virus (HSV). Planta Med 68: 780-783.
24. Coeugniet EG, Elek E (1987): Immunomodulation with Viscum album and Echinacea purpurea extracts. Onkologie 10: 27-33.
25. Viehmann P (1978): Results of treatment with an Echinacea-based ointment. Erfahrungsheilkunde 27: 353-358.
26. Coeugniet E, Kuhnast R (1986): Recurrent Candidiasis: Adjuvant immunotherapy, with different formulations of Echinacin. Therapiewochie 36: 3352-3358.
27. Skopińska-Różewska E. Wplyw Immunalu na odporność komórkowa̧ i humoralna̧. Ed. Lek Polska: 2002, 5-16.
28. Sokolnicka I, Skopińska-Różewska E, Strzelecka H, et al. (2001): Adaptacja testów biologicznych do oceny aktywności preparatów jeżówki purpurowej (Echinacea purpurea). Badania in vivo. Terapia 9/3 z. 2: 38-42.
29. Wojtulewicz-Kurkus J, Skopińska-Różewska E, Nowaczyk M, Podobińska I (1981): The effect of ampicillin on the response of human lymphocytes to PHA. Arch Immun Ther Exper 29: 361-368.
30. Chorostowska-Wynimko J, Kleniewska D, Sokolnicka I, et al. (1995): Lymphocyte mitogen-induced proliferation in patients with allergic rhinitis. Arch Immun Ther Exper 43: 217-220.
31. Sidky Y, Auerbach R (1975): Lymphocyte-induced angiogenesis, a quantitative and sensitive assay of the graft-versus-host reaction. J Exp Med 141: 1084-1093.
32. Majewski S, Skopińska-Różewska E, Jabłoń ska S, et al. (1985): Modulatory effect of sera from scleroderma patients on lymphocyte-induced angiogenesis. Arthritis and Rheumatism 10: 1133-1138.
33. Wójcik JK, Derentowicz P, Garliński P, Roszkowski W (1987): Effect of hydrocortisone, methylprednisolone and dexamethasone on the chemiluminescence of peripheral blood neutrophils. Pneumonol Pol 55: 154-158.
34. Radomska-Leśniewska D, Demkow U, Sokolnicka I, Chorostowska-Wynimko J (2001): Combined effects of antibiotics and immunomodulators on lymphocyte-induced angiogenesis. Terapia 9/3 z. 2: 10-13.
35. Mengs U, Clare CB, Poiley JA (1991): Toxicity of Echinacea purpurea. Acute, subacute and genotoxicity studies. Arzneimittelforschung 41 (10): 1076-1081.
36. Bergner P (1997): The healing Power of Echinacea and Goldenseal. Rocklin, CA. Prima Publishing, USA.